drugset / Trial / NCT03273231

The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection

NCT03273231 ↗

Unknown 100 enrolled Yonsei University
RandomizedParallel-groupTriple-blindOther

Summary

Systemic inflammation caused by surgery may aggravate immunosuppression in immunocompromised cancer patients. The natural killer (NK) cell is a critical part of anti-tumor immunity. ketamine, a N-methyl-D-asparate receptor antangonist, has anti-inflammatory activity and opioid-sparing effect. This study investigate the effect of intraopertaive ketamine administration on immune function in patients undergoing laparoscopic colorectal cancer resection.

Timeline

Start
2017-09-01
Primary completion
2020-07
Completion
2020-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.05 mg/kg Intravenous

Indications